CVA Family Office’s Aethlon Medical AEMD Stock Holding History

CVA Family Office’s Portfolio AEMD Stock Details AEMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-1	Closed	-$1K	–	898
2022 Q1	$1K	Hold	1	–	–	﹤0.01%	900
2021 Q4	$2K	Buy	+1	New	+$2.28K	﹤0.01%	823
2021 Q3	–	Sell	-1	Closed	-$5K	–	365
2021 Q2	$5K	Buy	+1	New	+$2.3K	﹤0.01%	755

Other funds holding AEMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Natixis Paris, France $28B AUM 26.79% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

NTB Financial Centennial, Colorado $123M AUM

CFN

Cordasco Financial Network Naples, Florida $138M AUM 10.5% 1-Year Est. Return

CVA Family Office's AEMD Position: Q2 2022 in Review

CVA Family Office sold out of Aethlon Medical (AEMD) in Q2 2022, closing a stake of 1 share — an estimated $1K sold.

CVA Family Office first reported a position in AEMD in Q2 2021 and held it in 3 quarters. The position peaked at $5K in Q2 2021. 22 funds tracked by Wall St. Rank hold AEMD as of Q2 2022.

CVA Family Office reported no remaining Aethlon Medical position as of Q2 2022 after selling out during the quarter.
CVA Family Office sold 1 Aethlon Medical share in Q2 2022, an estimated $1K.
CVA Family Office first reported a position in Aethlon Medical in Q2 2021 and held it in 3 quarters.
CVA Family Office's Aethlon Medical position peaked at $5K in Q2 2021.
22 funds tracked by Wall St. Rank held Aethlon Medical as of Q2 2022.

Based on CVA Family Office's 13F filing for Q2 2022, filed 11 Jul 2022.